GLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study
Balkan medical journal · 2026 Nov 2 · Gautam N, Huynh TM, Truong HH et
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 1 19:00 ETSource: Balkan medical journal
From the source
Read at pubmed.ncbi.nlm.nih.govGLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study
Balkan medical journal · 2026 Nov 2 · Gautam N, Huynh TM, Truong HH et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42969666/
